Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. Company
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Bayer AG
Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non

Number of employees : 99 538 people.
Sales per Business
20192020Delta
Crop Science19 832.0045.5%18 840.0045.5% -5%
Pharmaceuticals17 962.0041.2%17 243.0041.6% -4%
Consumer Health5 462.0012.5%5 054.0012.2% -7.47%
All Other Segments277.000.6%204.000.5% -26.35%
Reconciling Items12.000%59.000.1% +391.67%
EUR in Million
Sales per region
20192020Delta
United States13 556.0031.1%12 885.0031.1% -4.95%
Europe/Middle East/Africa10 315.0023.7%10 024.0024.2% -2.82%
Asia/Pacific4 885.0011.2%4 784.0011.6% -2.07%
China3 726.008.6%3 483.008.4% -6.52%
Brazil3 539.008.1%2 994.007.2% -15.4%
Latin America3 124.007.2%2 906.007% -6.98%
Germany2 364.005.4%2 361.005.7% -0.13%
North America1 531.003.5%1 467.003.5% -4.18%
Switzerland505.001.2%496.001.2% -1.78%
EUR in Million
Managers
Name Title Age Since
Werner Baumann Chairman-Management Board & CEO 58 2016
Wolfgang Nickl Chief Financial Officer 52 2018
Bijoy Sagar Chief Information Technology Officer 51 2020
Oliver Maier Head-Investor Relations 54 2017
Thomas Hoffmann, Dr. Head-Treasury 49 2019
Frank Rittgen Head-Mergers & Acquisitions 53 2012
Liam Condon President-Crop Science Division 53 2016
Heiko Willem-Jan Schipper Member-Management Board 52 2018
Stefan Oelrich President-Pharmaceuticals Division 53 2018
Marianne de Backer, Dr. EVP & Head-Global Business Development & Licensing 60 2019
Members of the board
Name Title Age Since
Norbert Winkeljohann Chairman-Supervisory Board 63 2020
Paul Achleitner Member-Supervisory Board 65 2002
Reiner Hoffmann Member-Supervisory Board 66 2006
Oliver Zühlke Vice Chairman-Supervisory Board 52 2015
André van Broich Member-Supervisory Board 51 2012
Petra Reinbold-Knape Member-Supervisory Board 62 2012
Michael Schmidt-Kiessling Member-Supervisory Board 62 1981
Simone Bagel-Trah Member-Supervisory Board 52 2014
Otmar D. Wiestler, Dr. Member-Supervisory Board 64 2014
Frank Löllgen Member-Supervisory Board 60 2015
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 982,424,082 982,422,261 100.0% 0 0.0% 100.0%
Shareholders
NameEquities%
Temasek Holdings Pte Ltd. (Investment Management) 34,629,635 3.52%
Harris Associates LP 29,633,044 3.02%
Norges Bank Investment Management 29,272,516 2.98%
The Vanguard Group, Inc. 25,500,110 2.60%
Fidelity Management & Research Co. LLC 13,873,322 1.41%
Dodge & Cox 13,619,992 1.39%
Amundi Asset Management SA (Investment Management) 11,806,014 1.20%
Massachusetts Financial Services Co. 11,724,803 1.19%
DWS Investments (UK) Ltd. 11,600,936 1.18%
Lyxor International Asset Management SAS 11,362,247 1.16%
Holdings
NameEquities%Valuation
BAYER CROPSCIENCE LIMITED (506285) 32,102,999 71.4% 2,290,751,228 USD
ELANCO ANIMAL HEALTH INCORPORATED (ELAN) 18,446,429 3.90% 588,256,621 USD
COVESTRO AG (1COV) 5,767,401 2.99% 396,636,221 USD
CENTURY THERAPEUTICS, INC. (IPSC) 12,675,838 23.3% 318,924,084 USD
ALLAKOS INC. (ALLK) 2,779,157 5.15% 294,229,352 USD
RECURSION PHARMACEUTICALS, INC. (RXRX) 7,453,926 4.69% 171,514,837 USD
PYXIS ONCOLOGY, INC. (PYXS) 2,742,338 8.38% 36,198,862 USD
Markets and indexes
- Prime Standard
- DAX 30 / Euro Stoxx 50, FTSE Eurotop 100, PEA, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  BAYGn:GR
- Reuters Code :  BAYGn.DE
- Datastream Code :  
Company contact information
Bayer AG
Kaiser-Wilhelm Allee 1
DE-51368 Leverkusen, Nordrhein-Westfalen

Phone : +49 214 30 1
Fax :
web site : https://www.bayer.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of Bayer AG
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
BAYER AG-3.20%53 140
JOHNSON & JOHNSON1.74%421 513
ROCHE HOLDING AG17.78%342 644
NOVO NORDISK A/S56.38%238 110
PFIZER, INC.12.71%231 668
ELI LILLY AND COMPANY41.54%216 655
MERCK & CO., INC.-5.68%195 296
ABBVIE INC.0.26%189 848
NOVARTIS AG-8.76%184 837
ASTRAZENECA PLC18.77%184 835
BRISTOL-MYERS SQUIBB COMPANY-8.21%126 527
SANOFI5.03%120 395
AMGEN INC.-11.65%115 348
GLAXOSMITHKLINE PLC3.99%95 804
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-27.60%56 443
JIANGSU HENGRUI MEDICINE CO., LTD.-46.59%48 664
DAIICHI SANKYO COMPANY, LIMITED-21.57%47 638
TAKEDA PHARMACEUTICAL COMPANY LIMITED-14.91%44 141
ASTELLAS PHARMA INC.21.71%32 115
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY54.41%25 515